Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
Showing session: reset
Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor
| Browse by: | Sort by: |
Welcome and Introduction
Sergio Fazio, MD, PhD
Oregon Health & Science University, Portland, OR
Free
Slides + audio
PCSK9 and The LDL-Receptor: Understanding the Biology
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
Free
Slides + audio
Patient Presentation
Keith Ferdinand, MD
Tulane University, New Orleans, LA
Don Davidson
New Orleans, LA
Free
Slides + audio
The Role of PCSK9 Inhibition in Cardiovascular Risk Reduction
Savitha Subramanian, MD
University of Washington, Seattle, WA
Free
Slides + audio
Who Needs Additional Lipid Lowering Drugs? - Finding the Right Patient
Eliot A Brinton, MD
Utah Lipid Center, Salt Lake City, UT
Free
Slides + audio
Panel Discussion and Audience Response Questions and Closing
Free
Slides + audio
